Trial Profile
Exploratory study of clinical effectiveness and safety of daikenchuto (TJ-100) for gastrointestinal symptoms such as abdominal pain and distention following laparoscopic colectomy in colon cancer patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2019
Price :
$35
*
At a glance
- Drugs TU 100 (Primary)
- Indications Postoperative ileus
- Focus Therapeutic Use
- 29 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Nov 2017 Trial design published in the Trials.
- 17 Sep 2017 Status changed from not yet recruiting to recruiting.